B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer?

The striking clinical outcomes of antibody-based immunotherapy, through the inhibitors of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and the programmed cell death protein-1 (PD-1) and its ligand (PD-L1) axis, have driven research aimed at identifying further clinically relevant tumor antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Malapelle, Umberto, Parente, Paola, Pepe, Francesco, Di Micco, Martina Concetta, Russo, Alessandro, Clemente, Celeste, Graziano, Paolo, Rossi, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788608/
https://www.ncbi.nlm.nih.gov/pubmed/36555714
http://dx.doi.org/10.3390/ijms232416077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788608/
https://www.ncbi.nlm.nih.gov/pubmed/36555714
http://dx.doi.org/10.3390/ijms232416077

Ejemplares similares